Senior Director, Clinical Research - Neurodegeneration in Maidenhead at Alnylampharmaceuticals | JobGan

Senior Director, Clinical Research - Neurodegeneration in Maidenhead

Alnylampharmaceuticals
Full time Senior
📡 Maidenhead, MA 🏙 Maidenhead, England 📅 Dec 31, 1969 ⏳ Closes Dec 20, 2026
💰 $150,000 – $172,500 CAD/yr
📋 Job Description

In the role of Senior Director, Clinical Research at Alnylam Pharmaceuticals, the successful candidate will provide vital clinical leadership in developing RNAi therapeutics, primarily focusing on Huntington’s program. Responsibilities include overseeing trial conduct, developing innovative drug strategies, and collaborating with various departments to ensure integrated product development. Candidates should possess an MD or MD PhD, along with a minimum of 10 years of experience in the industr

🔓

Sign up free to read the full details

Create your free account in 10 seconds and instantly unlock the complete job listing.

⚙️Requirements 🕐 Schedule 🔧 Skills 🔗 Apply Link

No spam · Free forever · Unsubscribe any time

Free Professional Certification & Career Pathway
Professional Employment Recommendation Certificate [Free]

Getting certified and Getting hired.



Access free courses, free exams, and verified certificates designed to build real, job-ready skills. Join a growing hiring network that connects learning directly to opportunities. This is not just training—it’s a pathway to getting certified and getting hired.

Click and Go to Course Library

HIRING COMPANY:
Alnylampharmaceuticals
📡 Maidenhead
Alnylam Pharmaceuticals is at the forefront of innovating RNA interference (RNAi) therapeutics, dedicated to transforming the treatment landscape for rare and prevalent diseases. Founded in 2002, Alnylam is driven by a commitment to scientific excellence and patient-centric solutions, leveraging Nobel Prize-winning sci…

Ready to Apply?

Submit your application directly to Alnylampharmaceuticals.

Free sign-up unlocks the full listing + apply link
⏳ Closes Dec 20, 2026
Senior Director, Clinical Research - Neurodegeneration in Maidenhead
Alnylampharmaceuticals · $150,000 – $172,500 CAD/yr